| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
5-(4-Hydroxy-benzylidene)-pyrimidine-2,4,6-trione manufacturers
- MHY-1685
-
- $29.00
-
2026-07-27
- CAS:27406-31-1
- Purity: 99.76%
- Supply Ability: 10g
|
| | 5-(4-Hydroxy-benzylidene)-pyrimidine-2,4,6-trione Basic information |
| Product Name: | 5-(4-Hydroxy-benzylidene)-pyrimidine-2,4,6-trione | | Synonyms: | IFLAB-BB F1208-0006;5-(4-HYDROXYBENZYLIDENE)BARBITURIC ACID;5-(4-HYDROXYBENZYLIDENE)PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE;5-(4-HYDROXYBENZYLIDENE)BARBUTIRIC ACID;2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-[(4-hydroxyphenyl)methylene]-;5-(4-hydroxyphenyl)methylenehexahydropyrimidine-2,4,6-trione;MHY-1685;MHY-1685,MHY1685,MHY 1685,inhibit,mTOR,Inhibitor,Mammalian target of Rapamycin | | CAS: | 27406-31-1 | | MF: | C11H8N2O4 | | MW: | 232.19 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File |  |
| | 5-(4-Hydroxy-benzylidene)-pyrimidine-2,4,6-trione Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO : 62.5 mg/mL (269.18 mM; Need ultrasonic) | | form | Solid | | color | Light yellow to yellow |
| | 5-(4-Hydroxy-benzylidene)-pyrimidine-2,4,6-trione Usage And Synthesis |
| Uses | MHY-1685, a novel mammalian target of rapamycin (mTOR) inhibitor, provides opportunities to improve hCSC-based myocardial regeneration. | | Biological Activity | MHY-1685, a novel mammalian target of rapamycin (mTOR) inhibitor, provides opportunities to improve hCSC-based myocardial regeneration. | | References | [1]. Park JH, et al. Human cardiac stem cells rejuvenated by modulating autophagy with MHY-1685 enhance the therapeutic potential for cardiac repair. Exp Mol Med. 2021 Sep;53(9):1423-1436. |
| | 5-(4-Hydroxy-benzylidene)-pyrimidine-2,4,6-trione Preparation Products And Raw materials |
|